Technical Analysis for VKTX - Viking Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 8.25 -4.07% -0.35
VKTX closed down 4.07 percent on Wednesday, July 17, 2019, on 78 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical VKTX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup -4.07%
Bollinger Band Squeeze Range Contraction -4.07%
BB Squeeze + Upper Band Touch Range Contraction -4.07%
Above Upper BB Strength -4.07%
Gapped Up Strength -4.07%

Older signals for VKTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for metabolic and endocrine disorders. Its lead clinical program includes VK0612, an orally available drug candidate for the treatment of type 2 diabetes. The company is also developing VK5211, an orally available drug candidate, which has completed Phase I trial for the treatment of cancer cachexia, a disease characterized by an uncontrolled decline in muscle mass. In addition, it is developing VK0214, a novel liver-selective thyroid hormone receptor beta agonist for lipid disorders, such as dyslipidemia and nonalcoholic steatohepatitis, as well as other preclinical programs for metabolic diseases and anemia. Viking Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.
Medicine Health Biopharmaceutical Cancer Medical Specialties Disease Diabetes Medication Treatment Of Cancer Anemia Hepatitis Metabolic Diseases Dyslipidemia Geriatrics Non Alcoholic Fatty Liver Disease Rehabilitation Medicine Steatohepatitis Lipid Disorders Cachexia
Is VKTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.0
52 Week Low 6.97
Average Volume 1,422,861
200-Day Moving Average 9.5952
50-Day Moving Average 8.1728
20-Day Moving Average 8.207
10-Day Moving Average 8.3
Average True Range 0.3359
ADX 8.89
+DI 20.7669
-DI 19.0655
Chandelier Exit (Long, 3 ATRs ) 7.692299999999999
Chandelier Exit (Short, 3 ATRs ) 8.8277
Upper Bollinger Band 8.5553
Lower Bollinger Band 7.8587
Percent B (%b) 0.56
BandWidth 8.487876
MACD Line 0.0562
MACD Signal Line 0.0354
MACD Histogram 0.0208
Fundamentals Value
Market Cap 228.5 Million
Num Shares 27.7 Million
EPS -0.83
Price-to-Earnings (P/E) Ratio -9.94
Price-to-Sales 0.00
Price-to-Book 10.84
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.96
Resistance 3 (R3) 9.00 8.82 8.84
Resistance 2 (R2) 8.82 8.64 8.79 8.80
Resistance 1 (R1) 8.53 8.53 8.44 8.49 8.76
Pivot Point 8.35 8.35 8.30 8.32 8.35
Support 1 (S1) 8.06 8.17 7.97 8.02 7.74
Support 2 (S2) 7.88 8.06 7.85 7.70
Support 3 (S3) 7.59 7.88 7.66
Support 4 (S4) 7.55